Kolexia
Pageot Nicolas
Neurologie
Clinique Beau Soleil
Montpellier, France
55 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose latérale amyotrophique Maladies du motoneurone Sclérose Maladies neuro-inflammatoires Fatigue Perte de poids Ataxie Trouble du comportement en sommeil paradoxal Maladie de Parkinson

Industries

Novartis
6 collaboration(s)
Dernière en 2023
Abbvie
3 collaboration(s)
Dernière en 2023
B3TSI
2 collaboration(s)
Dernière en 2021
Merz
2 collaboration(s)
Dernière en 2023

Dernières activités

Reversible sub-acute motor neuron syndrome after mushroom intoxication masquerading as amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis & frontotemporal degeneration   25 novembre 2021
Compound heterozygous P67S/D91A mutations in an ALS family with apparently sporadic case.
Amyotrophic lateral sclerosis & frontotemporal degeneration   20 octobre 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2.
Brain communications   29 juin 2021
Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France.
Amyotrophic lateral sclerosis & frontotemporal degeneration   12 février 2021
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.
EBioMedicine   07 juillet 2020
Low 25OH Vitamin D Blood Levels Are Independently Associated With Higher Amyotrophic Lateral Sclerosis Severity Scores: Results From a Prospective Study.
Frontiers in neurology   29 mai 2020
Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort.
Frontiers in neuroscience   28 avril 2020
Rhythm disturbances as a potential early marker of Parkinson's disease in idiopathic REM sleep behavior disorder.
Annals of clinical and translational neurology   14 février 2020
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study.
EClinicalMedicine   27 janvier 2020
Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
European journal of neurology   18 septembre 2019